Abstract 32: Implementation of Bedside CYP2C19 Genotype Testing and Personalization of Antiplatelet Therapy in Cardiac Catheterization Lab

MLA

Shahram Yazdani, et al. “Abstract 32: Implementation of Bedside CYP2C19 Genotype Testing and Personalization of Antiplatelet Therapy in Cardiac Catheterization Lab.” Circulation: Cardiovascular Quality and Outcomes, vol. 12, Apr. 2019. EBSCOhost, https://doi.org/10.1161/hcq.12.suppl_1.32.

APA

Shahram Yazdani, Manila Jindal, Ankit Vyas, Ramaswamy K. Iyer, Kelly Epps, Alexander Truesdale, Udaya S. Tantry, Kevin P. Bliden, Marjaneh Akbari, Heather Russell, Matthew W. Sherwood, Paul A. Gurbel, Hamid Taheri, & Behnam Tehrani. (2019). Abstract 32: Implementation of Bedside CYP2C19 Genotype Testing and Personalization of Antiplatelet Therapy in Cardiac Catheterization Lab. Circulation: Cardiovascular Quality and Outcomes, 12. https://doi.org/10.1161/hcq.12.suppl_1.32

Chicago

Shahram Yazdani, Manila Jindal, Ankit Vyas, Ramaswamy K. Iyer, Kelly Epps, Alexander Truesdale, Udaya S. Tantry, et al. 2019. “Abstract 32: Implementation of Bedside CYP2C19 Genotype Testing and Personalization of Antiplatelet Therapy in Cardiac Catheterization Lab.” Circulation: Cardiovascular Quality and Outcomes 12 (April). doi:10.1161/hcq.12.suppl_1.32.